Skip to main content
SpringerLink
Log in

Selektiver Melatoninagonist verhütet Delir

Somatisch akut schwer erkrankte ältere Patienten

  • journal club
  • Published:
InFo Neurologie & Psychiatrie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Hatta K, Kishi Y, Wada K et al, DELIRIA-J Group. Preventive effects of ramelteon on delirium: a randomized placebocontrolled trial. JAMA Psychiatry 2014; 71: 397–403

    Article  CAS  PubMed  Google Scholar 

Referenzen

  1. Al-Aama T et al. Int J Geriatr Psychiatry 2011; 26: 687–94

    Article  PubMed  Google Scholar 

  2. Bourne RS et al. Crit Care 2008; 12: R52

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich-Heine-Universität, LVR-Klinikum, Düsseldorf, Deutschland

    Christian Lange-Asschenfeldt (Ltd. Oberarzt Gerontopsychiatrie, Facharzt für Neurologie, Psychiatrie und Psychotherapie)

Authors
  1. Christian Lange-Asschenfeldt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christian Lange-Asschenfeldt.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lange-Asschenfeldt, C. Selektiver Melatoninagonist verhütet Delir. InFo Neurologie 16, 21 (2014). https://doi.org/10.1007/s15005-014-0924-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15005-014-0924-1

Search

Navigation